Retention of PDGFR-β function in mice in the absence of phosphatidylinositol 3′-kinase and phospholipase Cγ signaling pathways

  1. Michelle D. Tallquist1,
  2. Richard A. Klinghoffer1,
  3. Rainer Heuchel2,
  4. Peter F. Mueting-Nelsen1,
  5. Philip D. Corrin1,
  6. Carl-Henrik Heldin2,
  7. Richard J. Johnson3, and
  8. Philippe Soriano1,4
  1. 1Program in Developmental Biology and Division of Basic Sciences, Fred Hutchinson Cancer Research Center, Seattle, Washington 98109, USA; 2Ludwig Institute for Cancer Research, Biomedical Center, S-751 24 Uppsala, Sweden; 3Division of Nephrology, University of Washington, Seattle, Washington 98109, USA

Abstract

Signal transduction by the platelet-derived growth-factor receptor β (PDGFR-β) tyrosine kinase is required for proper formation of vascular smooth muscle cells (VSMC). However, the importance of individual PDGFR-β signal transduction pathways in vivo is not known. To investigate the role of two of the pathways believed to be critical for PDGF signal transduction, we have generated mice that bear a PDGFR-β that can no longer activate PI3kinase or PLCγ. Although these mutant mice have normal vasculature, we provide multiple lines of evidence in vivo and from cells derived from the mutant mice that suggest that the mutant PDGFR-β operates at suboptimal levels. Our observations indicate that although loss of these pathways can lead to attenuated PDGF-dependent cellular function, certain PDGFR-β-induced signal cascades are not essential for survival in mice.

Keywords

Footnotes

  • 4 Corresponding author.

  • E-MAIL psoriano{at}fhcrc.org; FAX (206) 667-6522.

  • Article and publication are at www.genesdev.org/cgi/doi/10.1101/gad.844700.

    • Received August 22, 2000.
    • Accepted October 31, 2000.
| Table of Contents

Life Science Alliance